Abstract
Memory CD8+ T cells have long been considered a promising population for adoptive cell therapy (ACT) due to their long-term persistence and robust re-stimulatory response. NIH3T3 is an immortalized mouse embryonic fibroblast cell line. We report that NIH3T3-conditioned medium (CM) can augment effector functions of CTLs following antigen priming and confer phenotypic and transcriptional properties of central memory cells. After NIH3T3-CM-educated CTLs were infused into naïve mice, they predominantly developed to central memory cells. A large number of NIH3T3-CM-educated CTLs with high functionality persisted and infiltrated to tumor mass. In addition, NIH3T3-CM inhibited CTLs expression of PD-1 in vitro and repressed their high expression of PD-1 in tumor microenvironment after adoptive transfer. Consequently, established tumor models showed that infusion of NIH3T3-CM-educated CTLs dramatically improved CTL mediated-antitumor immunity. Furthermore, NIH3T3-CM also promoted human CD8+ T cells differentiation into memory cells. These results suggest that NIH3T3-CM-programmed CTLs are good candidates for adoptive transfer in tumor therapy.
Original language | English |
---|---|
Article number | 761 |
Journal | Frontiers in immunology |
Volume | 10 |
Issue number | APR |
DOIs | |
Publication status | Published - 2019 |
Bibliographical note
Funding Information:This work was supported by a grant (NRF-2018R1A2A2A05023297) of the Basic Science Research Program of the National Research Foundation of Korea.
Publisher Copyright:
Copyright © 2019 Qin, Lee, Seo, Kim, Shin and Park.
Keywords
- Adoptive cell therapy
- Cytotoxic T lymphocytes
- Memory CD8+ T cells
- Memory precursor
- NIH3T3-CM
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology